Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Amlodipine Besylate; Telmisartan Patent Expiration

Amlodipine Besylate; Telmisartan is Used for managing high blood pressure. It was first introduced by Boehringer Ingelheim Pharmaceuticals Inc in its drug Twynsta on Oct 16, 2009. 5 different companies have introduced drugs containing Amlodipine Besylate; Telmisartan.


Amlodipine Besylate; Telmisartan Patents

Given below is the list of patents protecting Amlodipine Besylate; Telmisartan, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Twynsta US5591762 Benzimidazoles useful as angiotensin-11 antagonists Jan 07, 2014

(Expired)

 Boehringer Ingelheim



Amlodipine Besylate; Telmisartan's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Amlodipine Besylate; Telmisartan Generic API Manufacturers

Several generic applications have been filed for Amlodipine Besylate; Telmisartan. The first generic version for Amlodipine Besylate; Telmisartan was by Lupin Ltd and was approved on Jan 8, 2014. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Nov 17, 2016.

Given below is the list of companies who have filed for Amlodipine Besylate; Telmisartan generic, along with the locations of their manufacturing plants worldwide.